Are you interested in finding out more about best practices for CF care in
children? My name is Dr. Susanna McColley, and I'm Head of Pulmonary Medicine
and the Director of the Cystic Fibrosis Center of Children's Memorial Hospital
and associate professor of pediatrics, Northwestern University's Feinberg School
of Medicine.

On behalf of Genentech, I'll be doing a webcast entitled "Creating a Road Map
for Early CF Care" on Thursday, June 25, 2009 at 8:00 p.m. ET along with my
patient Jake and his mother Kelly to give you the straight talk on how to manage
your child's CF. I'll also answer questions from the audience live. Visit
www.pulmozyme.com to register for this information-packed webcast and submit
your questions today!


Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its
ingredients. Pulmozyme should be used in conjunction with standard therapies for
CF. When starting Pulmozyme therapy, patients may experience change in or loss
of voice, discomfort in the throat, chest pain, red watery eyes, rash,
dizziness, fever, or runny nose. These side effects are usually mild and
short-lived.